Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Cerebrospinal Fluid Biomarkers to Differentiate Idiopathic Normal Pressure Hydrocephalus from Subcortical Ischemic Vascular Disease

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Inflammation in Traumatic Brain Injury

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Neurotransmitter Imbalance in the Brain and Alzheimer’s Disease Pathology

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Normal pressure hydrocephalus secondary to Lyme disease, a case report and review of seven reported cases

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Living with the cerebellar mutism syndrome: long-term challenges of the diagnosis

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Introduction to the cerebellar mutism syndrome

    Research output: Contribution to journalComment/debateResearchpeer-review

  4. The supplementary motor area syndrome and the cerebellar mutism syndrome: a pathoanatomical relationship?

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Clinical and histopathological predictors of outcome in malignant meningioma

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

BACKGROUND: Idiopathic normal pressure hydrocephalus (iNPH) remains a challenge to differentiate from subcortical ischemic vascular disease (SIVD). Despite major research efforts, the cerebrospinal fluid (CSF) biomarker profiles of the two diseases are still not known in detail.

OBJECTIVE: To determine if novel CSF biomarkers, neurofilament light (NFL) reflecting axonal damage, the synaptic protein neurogranin (NG), and the astroglial marker chitinase-3-like protein 1 (YKL-40), and the core Alzheimer's disease (AD) biomarkers, amyloid-β 42 (Aβ42), total tau (t-tau), phosphorylated tau (p-tau), can differentiate iNPH from SIVD. Patients with AD and healthy controls (HC) were included for comparison purposes.

METHODS: Patients with iNPH (n = 28), SIVD (n = 30), AD (n = 57), and HC (n = 33) were retrospectively included from the Danish Dementia Biobank. All patients with iNPH had effect of shunt surgery with a follow-up period of 4 to 69 months. CSF biomarkers were measured using immunoassays.

RESULTS: Lower levels of NFL, NG, Aβ42, and t-tau were found in patients with iNPH versus SIVD, while YKL-40 and p-tau were similar in the two diseases. NFL and Aβ42 were the most reliable biomarkers to differentiate iNPH from SIVD with an area under the curve (AUC) on 0.82 and 0.80, respectively. Combining NFL with Aβ42, t-tau, and p-tau resulted in an AUC of 0.90, which was equivalent to the diagnostic accuracy of all six biomarkers combined.

CONCLUSION: An addition of NFL to the CSF panel of Aβ42, t-tau, and p-tau may improve the differentiation of iNPH from SIVD.

Original languageEnglish
JournalJournal of Alzheimer's Disease
Volume75
Issue number3
Pages (from-to)937-947
Number of pages11
ISSN1387-2877
DOIs
Publication statusPublished - 2020

ID: 60062443